Marianne Keessen
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A global phase II randomized trial comparing oral taxane ModraDoc006/r to intravenous docetaxel in metastatic castration resistant prostate cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 07, 2023
ModraDoc006, an oral docetaxel formulation in combination with ritonavir (ModraDoc006/r), in metastatic castration-resistant prostate cancer patients: A phase Ib study.
Journal: Cancer reports (Hoboken, N.J.)
Published: January 11, 2021
Effect of Food on the Pharmacokinetics of the Oral Docetaxel Tablet Formulation ModraDoc006 Combined with Ritonavir (ModraDoc006/r) in Patients with Advanced Solid Tumours.
Journal: Drugs in R&D
Published: December 27, 2020
A dose-escalation study of bi-daily once weekly oral docetaxel either as ModraDoc001 or ModraDoc006 combined with ritonavir.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 31, 2017
A Phase I Dose Escalation Study of Once-Weekly Oral Administration of Docetaxel as ModraDoc001 Capsule or ModraDoc006 Tablet in Combination with Ritonavir.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 17, 2017
The effect of St John's wort on the pharmacokinetics of docetaxel.
Journal: Clinical pharmacokinetics
Published: September 27, 2013
The effect of Echinacea purpurea on the pharmacokinetics of docetaxel.
Journal: British journal of clinical pharmacology
Published: December 12, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026